Surgical Therapy of End-Stage Heart Failure in Pediatric Patients

dc.contributor.authorAyik, F.
dc.contributor.authorOguz, E.
dc.contributor.authorEngin, C.
dc.contributor.authorYagdi, T.
dc.contributor.authorUlger, Z.
dc.contributor.authorAtay, Y.
dc.contributor.authorOzbaran, M.
dc.date.accessioned2019-10-27T21:24:32Z
dc.date.available2019-10-27T21:24:32Z
dc.date.issued2011
dc.departmentEge Üniversitesien_US
dc.description22nd Congress of the Spanish-Liver-Transplantation-Society (SETH) -- OCT 29-30, 2010 -- Madrid, SPAINen_US
dc.description.abstractObjective. We herein review our experience with ventricular assist device (VAD) implantation and heart transplantation in children with end-stage heart failure. Methods. We performed a retrospective nonrandomized review of all patients who underwent insertion of a Berlin Heart Excor VAD or heart transplantation in our clinic. The study spans from July 2005 to July 2010. We transplanted 11 patients of mean age 11.8 +/- 4.49 years, 3 of whom with critical hemodynamic situations were bridged to heart transplantation by VAD implantation. Despite the poor right ventricular systolic functions, they did not require right rVAD. In addition, 2 patients who underwent VAD implantation are still awaiting a donor heart. The mean follow-up was 825.27 +/- 630.23 days (range, 21-1,888 days). Results. There was no serious complication during VAD support. The overall heart transplantation mortality rate was 9.1% (1/11). In all patients, impaired end-organ functions were improved by VAD implantation before the heart transplantation. Cardiac biopsies revealed 4 grade 2R rejection episodes, which were successfully controlled in 3 patients. Conclusion. Heart transplantation is highly effective therapy for pediatric patients with end-stage heart failure. Pediatric VAD implantation provided satisfactory safe circulatory support for small children in poor condition on the waiting list. This option should be considered for all pediatric candidates who show a poor hemodynamic status.en_US
dc.description.sponsorshipSpanish Liver Transplantation Socen_US
dc.identifier.doi10.1016/j.transproceed.2011.01.100en_US
dc.identifier.endpage937en_US
dc.identifier.issn0041-1345
dc.identifier.issue3en_US
dc.identifier.pmid21486632en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage935en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2011.01.100
dc.identifier.urihttps://hdl.handle.net/11454/44576
dc.identifier.volume43en_US
dc.identifier.wosWOS:000289860300062en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSurgical Therapy of End-Stage Heart Failure in Pediatric Patientsen_US
dc.typeArticleen_US

Dosyalar